Literature DB >> 17021624

Contrast-enhanced ultrasound imaging of prostate cancer.

Ethan J Halpern.   

Abstract

Ultrasound imaging of the prostate is commonly used to assess the size of the gland and for needle placement during systematic biopsy. Ultrasound evaluation of prostate cancer is limited by difficulty in distinguishing benign from malignant tissue. Although Doppler techniques may provide some improvement in the detection of prostate cancer, targeted biopsy based on conventional ultrasound with Doppler is not sufficient to replace systematic biopsy. Contrast-enhanced ultrasound imaging techniques that employ microbubble contrast agents represent an innovative approach to imaging of the neovascularity associated with prostate cancer. This review describes the application of contrast-enhanced ultrasound to improve detection and assessment of prostate cancer.

Entities:  

Year:  2006        PMID: 17021624      PMCID: PMC1578528     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  60 in total

1.  Prostate cancer: contrast-enhanced us for detection.

Authors:  E J Halpern; M Rosenberg; L G Gomella
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

2.  Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent.

Authors:  A Broillet; J Puginier; R Ventrone; M Schneider
Journal:  Invest Radiol       Date:  1998-04       Impact factor: 6.016

Review 3.  Transrectal ultrasound of the prostate: innovations and future applications.

Authors:  R G Aarnink; H P Beerlage; J J De La Rosette; F M Debruyne; H Wijkstra
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

4.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.

Authors:  G J Jager; E T Ruijter; C A van de Kaa; J J de la Rosette; G O Oosterhof; J R Thornbury; S H Ruijs; J O Barentsz
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

5.  Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.

Authors:  D P Byar; F K Mostofi
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

6.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.

Authors:  Juyoung A Jung; Fergus V Coakley; Daniel B Vigneron; Mark G Swanson; Aliya Qayyum; Vivian Weinberg; Kirk D Jones; Peter R Carroll; John Kurhanewicz
Journal:  Radiology       Date:  2004-12       Impact factor: 11.105

7.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Comparison of microscopic vascularity in benign and malignant prostate tissue.

Authors:  S A Bigler; R E Deering; M K Brawer
Journal:  Hum Pathol       Date:  1993-02       Impact factor: 3.466

9.  Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms.

Authors:  T R Porter; F Xie
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

10.  Tumor-associated angiogenesis in prostate cancer.

Authors:  T A Fregene; P S Khanuja; A C Noto; S K Gehani; E M Van Egmont; D A Luz; K J Pienta
Journal:  Anticancer Res       Date:  1993 Nov-Dec       Impact factor: 2.480

View more
  22 in total

Review 1.  Clinical uses of microbubbles in diagnosis and treatment.

Authors:  David Cosgrove; Chris Harvey
Journal:  Med Biol Eng Comput       Date:  2009-02-10       Impact factor: 2.602

2.  Optimization of Contrast-to-Tissue Ratio Through Pulse Windowing in Dual-Frequency "Acoustic Angiography" Imaging.

Authors:  Brooks D Lindsey; Sarah E Shelton; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2015-03-25       Impact factor: 2.998

3.  Diagnostic accuracy of contrast-enhanced ultrasound in assessing the therapeutic response to radio frequency ablation for liver tumors: systematic review and meta-analysis.

Authors:  Min Xuan; Fengsheng Zhou; Yan Ding; Qiaoying Zhu; Ji Dong; Hao Zhou; Jun Cheng; Xiao Jiang; Pengxi Wu
Journal:  Surg Endosc       Date:  2017-12-21       Impact factor: 4.584

4.  Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer.

Authors:  C Nicolau; L Bunesch; L Peri; R Salvador; J M Corral; C Mallofre; C Sebastia
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

5.  Perspectives on high resolution microvascular imaging with contrast ultrasound.

Authors:  Thomas M Kierski; Paul A Dayton
Journal:  Appl Phys Lett       Date:  2020-05-26       Impact factor: 3.791

6.  Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.

Authors:  Natalie J Serkova
Journal:  Drug Resist Updat       Date:  2011-06-02       Impact factor: 18.500

7.  Evaluation of Frequency Domain Analysis of a Multiwavelength Photoacoustic Signal for Differentiating Malignant From Benign and Normal Prostates: Ex Vivo Study With Human Prostates.

Authors:  Saugata Sinha; Navalgund A Rao; Bhargava K Chinni; Vikram S Dogra
Journal:  J Ultrasound Med       Date:  2016-08-29       Impact factor: 2.153

8.  Use of ultrasound to facilitate difficult lumbar puncture in the pediatric oncology population.

Authors:  Shantanu Warhadpande; David Martin; Tarun Bhalla; Saif Rehman; Melissa Rose; Terri Guinipero; Joseph D Tobias
Journal:  Int J Clin Exp Med       Date:  2013-01-26

Review 9.  Ultrasound of the prostate.

Authors:  Michael Mitterberger; Wolfgang Horninger; Friedrich Aigner; Germar M Pinggera; Ilona Steppan; Peter Rehder; Ferdinand Frauscher
Journal:  Cancer Imaging       Date:  2010-03-03       Impact factor: 3.909

10.  Contrast-enhanced harmonic ultrasonography for the assessment of prostate cancer aggressiveness: a preliminary study.

Authors:  Yunkai Zhu; Yaqing Chen; Jun Jiang; Ren Wang; Yongchang Zhou; Huizhen Zhang
Journal:  Korean J Radiol       Date:  2009-12-28       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.